155 related articles for article (PubMed ID: 1820252)
1. Analysis and comparison of information and data recorded in carcinogenicity and genotoxicity databases.
Romano P; Aresu O; Parodi B; Malacarne D; Castagneto G; Parodi S; Ruzzon T
Environ Health Perspect; 1991 Dec; 96():113-20. PubMed ID: 1820252
[TBL] [Abstract][Full Text] [Related]
2. Examples of uses of databases for quantitative and qualitative correlation studies between genotoxicity and carcinogenicity.
Parodi S; Malacarne D; Taningher M
Environ Health Perspect; 1991 Dec; 96():61-6. PubMed ID: 1820280
[TBL] [Abstract][Full Text] [Related]
3. International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE.
Klopman G; Rosenkranz HS
Mutat Res; 1994 Feb; 305(1):33-46. PubMed ID: 7508546
[TBL] [Abstract][Full Text] [Related]
4. The genetic toxicity database of the National Toxicology Program: evaluation of the relationships between genetic toxicity and carcinogenicity.
Tennant RW
Environ Health Perspect; 1991 Dec; 96():47-51. PubMed ID: 1820276
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenicity evaluations and ongoing studies: the IARC databases.
Vainio H; Coleman M; Wilbourn J
Environ Health Perspect; 1991 Dec; 96():5-9. PubMed ID: 1820277
[TBL] [Abstract][Full Text] [Related]
6. Data selection and treatment of chemicals tested for genotoxicity and carcinogenicity.
Loprieno N; Boncristiani G; Loprieno G; Tesoro M
Environ Health Perspect; 1991 Dec; 96():121-6. PubMed ID: 1820253
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole: an exploration of its reported genotoxicity.
Rosenkranz HS; Klopman G
Mutagenesis; 1991 Sep; 6(5):381-4. PubMed ID: 1795642
[TBL] [Abstract][Full Text] [Related]
8. Short-term tests for defining mutagenic carcinogens.
Waters MD; Stack HF; Jackson MA
IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relations: maximizing the usefulness of mutagenicity and carcinogenicity databases.
Klopman G; Rosenkranz H
Environ Health Perspect; 1991 Dec; 96():67-75. PubMed ID: 1820281
[TBL] [Abstract][Full Text] [Related]
10. Aspects of database construction and interrogation of relevance to the accurate prediction of rodent carcinogenicity and mutagenicity.
Ashby J
Environ Health Perspect; 1991 Dec; 96():97-100. PubMed ID: 1820286
[TBL] [Abstract][Full Text] [Related]
11. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
Kirkland D; Reeve L; Gatehouse D; Vanparys P
Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the predictivity of some short-term assays for carcinogenicity in rodents.
Klopman G; Rosenkranz HS
Mutat Res; 1991 Dec; 253(3):237-40. PubMed ID: 1720198
[TBL] [Abstract][Full Text] [Related]
13. The Carcinogenic Potency Database: analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program.
Gold LS; Slone TH; Manley NB; Garfinkel GB; Hudes ES; Rohrbach L; Ames BN
Environ Health Perspect; 1991 Dec; 96():11-5. PubMed ID: 1820251
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs.
Brambilla G; Mattioli F; Robbiano L; Martelli A
Basic Clin Pharmacol Toxicol; 2013 May; 112(5):302-13. PubMed ID: 23374861
[TBL] [Abstract][Full Text] [Related]
15. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
17. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
18. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
Kim BS; Margolin BH
Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
[TBL] [Abstract][Full Text] [Related]
19. Genetic toxicology: can we design predictive in vivo assays?
Clive D
Mutat Res; 1988; 205(1-4):313-30. PubMed ID: 3285193
[TBL] [Abstract][Full Text] [Related]
20. Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics.
Brambilla G; Martelli A
Pharmacol Res; 2009 Jul; 60(1):1-17. PubMed ID: 19427580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
